Valorisation of lagenaria siceraria leaves as a sustainable source of triterpenoid and polyphenolic constituents for cardiometabolic protection
نویسندگان
doi
10.48309/jmpcr.2026.562806.1916چکیده
Cardiometabolic diseases (CMDs) including diabetes, dyslipidemia, obesity, and cardiovascular disorders are closely associated with oxidative stress and metabolic dysregulation. This study investigated the cardiometabolic protective potential of a chloroform extract of Lagenaria siceraria leaves (CELS) through integrated phytochemical, in vitro, and in vivo evaluations. Sequential Soxhlet extraction was performed using solvents of increasing polarity. Antioxidant assays (DPPH, superoxide, FRAP, and total antioxidant), enzyme inhibition (α-amylase, α-glucosidase, pancreatic lipase, and HMG-CoA reductase), and phytochemical profiling were conducted, with compound identification by GC–MS and LC–MS/MS. In vivo efficacy was assessed in high-fat diet plus streptozotocin (HFD + STZ)-induced rats treated orally with CELS (250 and 500 mg/kg) for 28 days, using metformin as the reference drug. The chloroform extract exhibited balanced antioxidant and enzyme-inhibitory activities, and contained triterpenoids (lupeol and squalene), phytosterols (β-sitosterol and campesterol), and polyphenols (chlorogenic acid, quercetin, and rutin). CELS significantly (p < 0.001) reduced fasting blood glucose (FBG), HbA1c, triglycerides, total cholesterol, and hepatic and cardiac injury markers, while restoring HDL levels and antioxidant enzymes, and reducing malondialdehyde levels. Improvements in organ weight and tissue histoarchitecture further support systemic protection. Overall, CELS demonstrated significant cardiometabolic protective potential, highlighting CELS as a sustainable source of bioactive phytochemicals for cardiometabolic disease management.